| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 100,896 | 180,037 | 73,737 | 85,945 | | Cost of Revenue |
-
|
-
|
-
| 344,278 | | | Gross Profit | 100,896 | 180,037 | 73,737 | (258,333) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 98,436 | 128,915 | 82,732 | (270,354) | | Non Recurring |
-
|
-
|
-
| 17,200 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,460 | 51,122 | (8,995) | (5,179) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 715 | 664 | 443 | 663 | | Earnings Before Interest And Taxes | 2,607 | 51,391 | (8,230) | (4,923) | | Interest Expense | 245 | 211 | 316 | 659 | | Income Before Tax | 2,362 | 51,180 | (8,546) | (5,582) | | Income Tax Expense | 3,578 | 20,324 | (3,479) | (2,116) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,216) | 30,856 | (5,067) | (3,466) | | | Non-recurring Events | | Discontinued Operations | (1,109) | 5 | 241 | (607) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,325) | 30,861 | (4,826) | (4,073) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,325) | $30,861 | ($4,826) | ($4,073) |
|
1.47% Nasdaq 
Income Statement
